P170 in chronic myeloid leukemia
Daniela Damiani(University of Bologna), Michele Baccarani(University of Bologna), Donatella Raspadori(University of Udine), Mariagrazia Michieli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Daniel Russo(IT University of Copenhagen), Marinella Velisig(University of Udine), Angela Michelutti(University of Udine), Cristina Melli(University of Udine), F. Salmaso(University of Udine), Laura Infanti
Cited by 0
Related Papers
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia
|Blood|2011|460
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
|Blood|2013|391